ACRV
Price:
$6.36
Market Cap:
$198.03M
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in a potentially registrational Phase 2 trial across various tumor...[Read more]
Industry
Biotechnology
IPO Date
2022-11-15
Stock Exchange
NASDAQ
Ticker
ACRV
According to Acrivon Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 158.62M. This represents a change of 2.43% compared to the average of 154.86M of the last 4 quarters.
The mean historical Enterprise Value of Acrivon Therapeutics, Inc. Common Stock over the last ten years is 225.98M. The current 158.62M Enterprise Value has changed 6.92% with respect to the historical average. Over the past ten years (40 quarters), ACRV's Enterprise Value was at its highest in in the September 2022 quarter at 286.05M. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.
Average
225.98M
Median
240.55M
Minimum
77.25M
Maximum
345.58M
Discovering the peaks and valleys of Acrivon Therapeutics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 345.58M
Minimum Annual Increase = -66.11%
Minimum Annual Enterprise Value = 77.25M
Year | Enterprise Value | Change |
---|---|---|
2023 | 77.25M | -66.11% |
2022 | 227.97M | -9.94% |
2021 | 253.13M | -26.75% |
The current Enterprise Value of Acrivon Therapeutics, Inc. Common Stock (ACRV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
186.12M
5-year avg
225.98M
10-year avg
225.98M
Acrivon Therapeutics, Inc. Common Stock’s Enterprise Value is greater than Aerovate Therapeutics, Inc. (43.34M), greater than Adagene Inc. (8.35M), less than Rezolute, Inc. (248.88M), greater than AN2 Therapeutics, Inc. (8.33M), greater than Anebulo Pharmaceuticals, Inc. (31.01M), greater than PMV Pharmaceuticals, Inc. (42.60M), greater than Molecular Partners AG (107.67M), less than Mineralys Therapeutics, Inc. (502.94M), less than AnaptysBio, Inc. (250.00M), less than Opthea Limited (552.77M),
Company | Enterprise Value | Market cap |
---|---|---|
43.34M | $73.92M | |
8.35M | $83.23M | |
248.88M | $257.27M | |
8.33M | $41.83M | |
31.01M | $32.42M | |
42.60M | $78.14M | |
107.67M | $200.54M | |
502.94M | $600.21M | |
250.00M | $425.09M | |
552.77M | $4.57B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acrivon Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acrivon Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Acrivon Therapeutics, Inc. Common Stock's Enterprise Value?
What is the highest Enterprise Value for Acrivon Therapeutics, Inc. Common Stock (ACRV)?
What is the 3-year average Enterprise Value for Acrivon Therapeutics, Inc. Common Stock (ACRV)?
What is the 5-year average Enterprise Value for Acrivon Therapeutics, Inc. Common Stock (ACRV)?
How does the current Enterprise Value for Acrivon Therapeutics, Inc. Common Stock (ACRV) compare to its historical average?